COVID-19 — Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19
Citation(s)
A Prospective, Randomized, Placebo-controlled, Double-blinded, Phase III Clinical Trial of the Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19